Larynx cancer risk in relation to glutathione S-transferase M1 and T1 genotypes and tobacco smoking

Cancer Epidemiology Biomarkers and Prevention

Volumn 7, Issue 1, 1998, Pages 19-23

  Jourenkova, Nadejda ^a   Reinikainen, Maria ^b   Bouchardy, Christine ^c   Dayer, Pierre ^d   Benhamou, Simone ^a   Hirvonen, Ari ^b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c GENEVA CANCER REGISTRY   (Switzerland)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; DNA; GLUTATHIONE TRANSFERASE; ISOENZYME;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DETOXIFICATION; ENZYME ACTIVITY; FEMALE; GENE; GENE DELETION; GENOTYPE; HUMAN; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SMOKING; TOBACCO;

AGED; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FRANCE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING;

EID: 0031909254     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Cattaruzza, M. S., Maisonneuve, P., and Boyle, P. Epidemiology of laryngeal cancer. Eur. J. Cancer Oral. Oncol., 32B: 293-305, 1996.
2. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans. Vol. 38, Tobacco Smoking. Lyon, France: IARC, 1986.
3. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 44, Alcohol Drinking. Lyon, France, IARC, 1988.
4. Ketterer, B., Harris, J. M., Talaska, G., Meyer, D. J., Pemble, S. E., Taylor, J. B., Lang, N. P., and Kadlubar, F. F The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer. Environ. Health Perspect., 98: 87-94, 1992.
5. Seidegard, J , Vorachek, W R., and Pero, R. W. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc. Natl. Acad Sci. USA, 85: 7293-7297, 1988.
6. Pemble, S., Schroeder, K. R., Spencer, S R., Meyer, D. J., Hallier, E., Bolt, H. M., Ketterer, B., and Taylor, J. B Human glutathione S-transferase θ (GSTTI): cDNA cloning and the characterization of a genetic polymorphism. Biochem J., 300: 271-276, 1994.
7. Guengerich, F. P., Thier, R., Persmark, M., Taylor, J. B , Pemble, S. E , and Ketterer B. Conjugation of carcinogens by θ class glutathione S-transferases: mechanisms and relevance to variations in human risk Pharmacogenetics, 5: S103-S107, 1995.
8. Lafuente, A., Pujol, F., Carretero, P., Villa, J. P., and Cuchi, A Human glutathione S-transferase μ (GST μ) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. Cancer Lett., 68: 49-54, 1993.
9. Coutelle, C., Ward, P. J , Fleury, B., Quattrocchi, P., Chambrin, H., Iron, A., Couzigou, P., and Cassaigne, A Laryngeal and oropharyngeal cancer, and alcohol dehydrogenase 3 and glutathione S-transferase M1 polymorphisms Hum. Genet., 99: 319-325, 1997.
10. Jahnke, V , Matthias, C , Fryer, A , and Strange, R. Glutathione S-transferase and cytochrome P-450 polymorphism as risk factors for squamous cell carcinoma of the larynx Am J. Surg., 172: 671-673, 1996.
11. Bouchardy, C., Benhamou, S , and Dayer, P. The effect of tobacco on lung cancer risk depends on CYP2D6 activity Cancer Res., 56: 251-253, 1996.
12. Benhamou, S., Bouchardy, C., Paoletti, C., and Dayer, P. Effects of CYP2D6 activity and tobacco on larynx cancer risk. Cancer Epidemiol. Biomark Prev , 5: 683-686, 1996.
13. Chen, H , Sandler, D. P., Taylor, J. A., Shore, D. L., Liu, E., Bloomfield, C. D., and Bell, D. A. Increased risk for myelodysplastic syndromes in individuals with glutathione transferase θ 1 (GSTTI) gene defect. Lancet, 347: 295-297, 1996.
14. Hirvonen, A., Saarikoski, S. T., Linnainmaa, K., Koskinen, K., Husgafvel-Pursiainen, K., Mattson, K., and Vainio, H Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders. J. Natl. Cancer Inst., 88: 1853-1856, 1996.
15. WHO International Classification of Diseases for Oncology, pp 6-7. Geneva: WHO, 1976.
16. Tuyns, A. J., Esteve, J., Raymond, L., Berrino, F., Benhamou, E , Blanchet, F., Boffetta, P., Crosignani, P., Del Moral, A., Lehmann, W., Merletti, F , Pequignot, G , Riboli, E , Sancho-Garnier, H., Terracini, B., Zubiri, A., and Zubin, L. Cancer of the larynx/hypopharynx, tobacco and alcohol: IARC international case-control study in Turin and Varese (Italy), Zaragoza and Navarra (Spain), Geneva (Switzerland) and Calvados (France). Int. J. Cancer, 41: 483-491, 1988.
17. Breslow, N. E., and Day, N. E. Statistical Methods in Cancer Research I. The Analysis of Case-Control Studies. IARC Scientific Publ. No. 35, pp. 192-242. Lyon, France: IARC, 1980.
18. d'Errico, A., Taioli, A , Chen, X , and Vineis, P. Genetic metabolic polymorphisms and the risk of cancer: a review of the literature Biomarkers, 1: 149-173, 1996.
19. Garcia-Closas, M., Kelsey, K. T., Wiencke, J. K., Xu, X., Wain, J. C., and Christiani, D. C A case-control study of cytochrome P450 IAI, glutathione S-transferase M1, cigarette smoking and lung cancer susceptibility. Cancer Causes Control, 8: 544-553, 1997.
20. To-Figueras, J , Gene, M., Gomez-Catalan, J., Galan, M. C., Fuentes, M., Ramon, J. M., Rodamilans, M., Huguet, E., and Corbella, J. Glutathione S-transferase M1 (GSTMI) and T1 (GSTTI) polymorphisms and lung cancer risk among Northwestern Mediterraneans. Carcinogenesis (Lond.), 18: 1529-1533, 1997.
21. Khuri, F R , Lippman, S. M , Spitz, M. R., Lotan, R., and Hong, W K. Molecular epidemiology and retinoid chemoprevention of head and neck cancer J. Natl. Cancer Inst., 89: 199-211, 1997.
22. Trizna, Z , Clayman, G. L., Spitz, M. R., Briggs, K. L., and Goepfert, H. Glutathione S-transferase genotypes as risk factors for head and neck cancer. Am. J. Surg., 170: 499-501, 1995.
23. Kelsey, K. T., Spitz, M R., Zuo, Z. F , and Wiencke, J K. Polymorphisms in the glutathione S-transferase class μ and θ genes interact and increase susceptibility to lung cancer in minority populations. Cancer Causes Control, 8: 554-559, 1997.
24. Scarpato, R., Hirvonen, A , Mighore, L., Falck, G., and Norppa, H. Influence of GSTMI and GSTTI polymorphisms on the frequency of chromosome aberrations in lymphocytes of smokers and pesticide-exposed greenhouse workers. Mutat. Res., 389: 227-235, 1997.
25. Doll, R., and Peto, R Mortality in relation to smoking: 20 years' observations on male British doctors. Br. Med. J., 2: 1525-1536, 1976.
26. Launoy, G., Milan, C. H , Faivre, J., Pienkovski, P., Milan, C I., and Gignoux, M. Alcohol, tobacco and oesophageal cancer effects of the duration of consumption, mean intake and current and former consumption. Br. J. Cancer, 75: 1389-1396, 1997.
27. Vineis, P. Molecular epidemiology: low-dose carcinogens and genetic susceptibility. Int. J. Cancer, 71: 1-3, 1997.
28. London, S. J., Daly, A K., Cooper, J., Navidi, W. C., Carpenter, C. L., and Idle, J. R. Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California. J Natl Cancer Inst., 87: 1246-1253, 1995.
29. Nakachi, K., Imai, K., Hayashi, S., and Kawajiri, K. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res., 53: 2994-2999, 1993.
30. Vineis, P., Bartsch, H., Caporaso, N., Harrington, A. M., Kadlubar, F. F., Landi, M T., Malaveille, C., Shields, P. G., Skipper, P., Talaska, G., and Tannenbaum, S. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature (Lond), 369: 154-156, 1994.
31. Guengerich, F. P., Kim, D. H., and Iwasaki, M. Role of human cytochrome P-450 IIEI in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol., 4: 168-179, 1991.